Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.
about
Stem cells, colorectal cancer and cancer stem cell markers correlationsCD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysisCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesAssociation between NQO1 C609T polymorphism and prostate cancer riskPrognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaPrognostic role of CD133 expression in colorectal cancer: a meta-analysisCancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.Prognostic value of stem cell quantification in stage II colon cancer.Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysisPrognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis.Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.Combinatorial immunotherapy of sorafenib and blockade of programmed death-ligand 1 induces effective natural killer cell responses against hepatocellular carcinoma.Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.Association between IL-4 -589C>T polymorphism and colorectal cancer risk.Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma.Immunopathological characterization of cryptoglandular anal fistula: a pilot study investigating its pathogenesis.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies.Colonic Stem Cells Expression of Lgr5 and CD133 Proteins as Predictive Markers in Colorectal Cancer among Egyptian Patients.
P2860
Q26823217-B186F377-377B-4657-A00E-17A714A46253Q26827628-AEC4664B-7920-4320-BBC6-9B63C5683C65Q27024651-A9B845B2-16D1-4DCE-9EB9-9D31318CD042Q28240340-D172570C-3906-4AC1-BFF9-C6A9454AF29EQ34486212-4ADCA60E-F85C-4A05-9D23-7EEA8128CE53Q34502600-4831310E-031B-460A-A190-9EBF8624DE41Q34984086-0F64F886-A5EF-4BC7-A5E7-2186A41E2D5DQ35106095-9743737B-77AE-4289-843F-5F5A09918783Q35833372-6CEAE38E-92C3-484C-875F-8D73748BA018Q35870637-E669600D-7CCC-46D5-9900-80C8B42CE120Q35899912-AC6C4440-1A62-462D-A459-34FCA7EDB79CQ36962860-AB6EB55A-EF1B-4C54-991E-A21BEACCC89BQ37563260-455A65CF-E183-41B8-8987-66E329736F8BQ38163598-255E174B-3923-4BF2-A6CB-4B3D932B56FFQ38977452-CC0E5F72-63F8-4B33-8412-2B8FB2B1ED2FQ41676912-079F6382-24B6-4DBF-BB91-A359680E7A50Q46403034-6A04DC52-B89C-446D-B539-0C010F9E45EBQ46735674-284FD72D-6FDE-4747-B426-3A7D2A818E24Q50676592-D58068B4-3AA4-4C12-9B2F-B1EC37B03935Q51484243-BA23A4B5-D01F-485F-BFEE-60D0BE81A725Q53134069-A99628C0-4070-4D38-8116-2BD017261E8EQ55285304-08FBA3C4-2800-4B48-80FC-493B379D2370Q55516194-B3A16AD3-B843-4B22-AB59-2D04700C01A2
P2860
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Increased expression of CD133 ...... come in colon cancer patients.
@ast
Increased expression of CD133 ...... come in colon cancer patients.
@en
type
label
Increased expression of CD133 ...... come in colon cancer patients.
@ast
Increased expression of CD133 ...... come in colon cancer patients.
@en
prefLabel
Increased expression of CD133 ...... come in colon cancer patients.
@ast
Increased expression of CD133 ...... come in colon cancer patients.
@en
P2093
P2860
P356
P1476
Increased expression of CD133 ...... tcome in colon cancer patients
@en
P2093
Achille Cittadini
Alma Boninsegna
Claudio Coco
Egidio Stigliano
Emanuele Caredda
Gian Franco Zannoni
Gianluca Rizzo
Giannicola Genovese
Luca Reggiani Bonetti
Mario Migaldi
P2860
P2888
P356
10.1186/1756-9966-31-71
P577
2012-09-11T00:00:00Z
P5875
P6179
1017345355